CAS No. 154361-50-9  | Capecitabine
CAS No. 154361-50-9  | Capecitabine
CAS No. 154361-50-9  | Capecitabine
CAS No. 154361-50-9  | Capecitabine
+
  • CAS No. 154361-50-9  | Capecitabine
  • CAS No. 154361-50-9  | Capecitabine
  • CAS No. 154361-50-9  | Capecitabine
  • CAS No. 154361-50-9  | Capecitabine

CAS No. 154361-50-9 | Capecitabine

Name: Capecitabine CAS No. 154361-50-9 MF:C15H22FN3O6 MW:359.35 Purity:98% Package: 5g,25g,200g,500g,1kg Worldwide Delivery

Categories:

Other Life Science Chemicals

Product introduction

Introduction and application of  CAS No. 154361-50-9  | Capecitabine

 

Synonyms:5'-DEOXY-5-FLUOROCYTISINE;

5'-DEOXY-5-FLUORO-N-[(PENTYLOXY)CARBONYL]CYTIDINE;

Pentyl(1-((2R,3R,4S,5R)-3,4-dihydroxy-5-methyltetrahydrofuran-2-yl)-5-fluoro-2-oxo-1,2-dihydr;

pentyl[1-(3,4-dihydroxy-5-methyl-oxolan-2-yl)-5-fluoro-2-oxo-pyrimidin-4-yl]aminoformate;

CAPECITABINE;

Cpecitabine;

5Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine,Ro-9-1978,Xeloda

 

Specification:

ITEMS

SPECIFICATION

CAS

154361-50-9

MF

C15H22FN3O6

MW

359.35

Melting point

110-121°C

Flash point

87℃

Density

1.49±0.1 g/cm3

Acidity coefficient

5.41±0.40

Color

white to beige

Solubility

H2O: soluble 10mg/mL, transparent (heated)

Form

Powder

Storage condition

2-8°C

Capecitabine is an antimetabolite fluoropyrimidine deoxynucleoside carbamate drug that can be converted into 5-FU in the body. It can inhibit cell division and interfere with RNA and protein synthesis. It is suitable for the further treatment of advanced primary or metastatic breast cancer that is ineffective with paclitaxel and chemotherapy regimens including anthracycline antibiotics. Mainly used for the treatment of advanced primary or metastatic breast cancer, rectal cancer, colon cancer and gastric cancer.

 

Package and transportation :

Package: 5g,25g,200g,500g,1kg

Transportation: by courier/ by air/ by sea

Key words:

Related Products

Related Products

Inquiry

SUBMIT